These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52 related articles for article (PubMed ID: 45194)
1. Characterization of the multiple forms of monoamine oxidase from chronic schizophrenic sera. Al-Mudhaffar SA; Fahad NM Biochem Exp Biol; 1979; 15(4):317-27. PubMed ID: 45194 [TBL] [Abstract][Full Text] [Related]
2. Multiple forms of monoamine oxidase in chronic schizophrenia. Al-Mudhaffar SA; Fahad NM Biochem Exp Biol; 1979; 15(4):311-6. PubMed ID: 552271 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the binding of [3H]Ro 41-1049 to the active site of human monoamine oxidase-A. Cesura AM; Bös M; Galva MD; Imhof R; Da Prada M Mol Pharmacol; 1990 Mar; 37(3):358-66. PubMed ID: 2314388 [TBL] [Abstract][Full Text] [Related]
4. [Multiple forms of thrombocyte monoamine oxidase in patients with manic-depressive psychosis and recurrent schizophrenia]. Smirnov AV; Prilipko LL Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(4):76-8. PubMed ID: 3414255 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of a type B monoamine oxidase inhibitor, (E)-2-(4-fluorophenethyl)-3-fluoroallylamine (MDL-72974A), on semicarbazide-sensitive amine oxidases isolated from vascular tissues and sera of different species. Yu PH; Zuo DM Biochem Pharmacol; 1992 Jan; 43(2):307-12. PubMed ID: 1739419 [TBL] [Abstract][Full Text] [Related]
6. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl]. Severina IS Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation. Youdim MB; Weinstock M Neurotoxicology; 2004 Jan; 25(1-2):243-50. PubMed ID: 14697899 [TBL] [Abstract][Full Text] [Related]
8. [Isolation and characterization of an evolutionary precursor of human monoamine oxidases A and B]. Singer TP; Iankovskaia VL; Bernard S; Cronin C; Sablin SO Vopr Med Khim; 1997; 43(6):440-56. PubMed ID: 9503562 [TBL] [Abstract][Full Text] [Related]
9. Photoaffinity labeling of human placental monoamine oxidase-A by 4-fluoro-3-nitrophenyl azide. Hsu MC; Shih JC Mol Pharmacol; 1988 Feb; 33(2):237-41. PubMed ID: 3340083 [TBL] [Abstract][Full Text] [Related]
10. [Monoamine oxidase inhibitors and pressor response to dietary amines]. Tipton KF Vopr Med Khim; 1997; 43(6):494-503. PubMed ID: 9503566 [TBL] [Abstract][Full Text] [Related]
11. [Heterogeneity of platelet monoamine oxidase in man]. Moskvitina TA Biull Eksp Biol Med; 1990 Feb; 109(2):152-3. PubMed ID: 2337649 [TBL] [Abstract][Full Text] [Related]
12. Assessment of the deamination of aminoacetone, an endogenous substrate for semicarbazide-sensitive amine oxidase. Deng Y; Yu PH Anal Biochem; 1999 May; 270(1):97-102. PubMed ID: 10328770 [TBL] [Abstract][Full Text] [Related]
13. Comparison of biochemical properties of platelet monoamine oxidase in mentally disordered and healthy individuals. Yu PH; Bowen R; Carlson K; O'Sullivan K; Boulton AA Psychiatry Res; 1982 Feb; 6(1):107-21. PubMed ID: 6949165 [TBL] [Abstract][Full Text] [Related]
15. Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide. Visentin V; Bour S; Boucher J; Prévot D; Valet P; Ordener C; Parini A; Carpéné C Eur J Pharmacol; 2005 Oct; 522(1-3):139-46. PubMed ID: 16202994 [TBL] [Abstract][Full Text] [Related]
16. Evidence for a clorgyline-resistant monoamine metabolizing activity in the rat heart. Lyles GA; Callingham BA J Pharm Pharmacol; 1975 Sep; 27(9):628-91. PubMed ID: 241805 [TBL] [Abstract][Full Text] [Related]